Review Article
DNA Vaccines: Developing New Strategies against Cancer
Table 3
Adjuvant molecules employed in cancer clinical trials to enhance the immune response.
| Adjuvant | Phase | References |
| Genetic | cytokines | I/II-II | NCT00019448 | (GM-CSF, IL-12, IL-2) | [56, 62] | bacterial toxins | I/II | [46, 47, 64, 65] | (pDOM/tetanus toxin FrC) | immunomodulatory molecules (HSP70) | I/II | [67] |
| Protein | cytokines (GM-CSF, IL-2) | I/II-II | [58, 59, 61]; |
|
|